KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

West Pharmaceutical Services (WST) Interest Expenses (2016 - 2025)

Historic Interest Expenses for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to $200000.0.

  • West Pharmaceutical Services' Interest Expenses fell 7142.86% to $200000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$100000.0, marking a year-over-year decrease of 10200.0%. This contributed to the annual value of $3.0 million for FY2024, which is 6666.67% down from last year.
  • Per West Pharmaceutical Services' latest filing, its Interest Expenses stood at $200000.0 for Q3 2025, which was down 7142.86% from $100000.0 recorded in Q2 2025.
  • West Pharmaceutical Services' 5-year Interest Expenses high stood at $2.9 million for Q3 2023, and its period low was -$800000.0 during Q4 2024.
  • Over the past 5 years, West Pharmaceutical Services' median Interest Expenses value was $1.8 million (recorded in 2021), while the average stood at $1.5 million.
  • As far as peak fluctuations go, West Pharmaceutical Services' Interest Expenses surged by 5000.0% in 2023, and later crashed by 16666.67% in 2024.
  • Over the past 5 years, West Pharmaceutical Services' Interest Expenses (Quarter) stood at $2.6 million in 2021, then plummeted by 34.62% to $1.7 million in 2022, then decreased by 29.41% to $1.2 million in 2023, then tumbled by 166.67% to -$800000.0 in 2024, then skyrocketed by 125.0% to $200000.0 in 2025.
  • Its Interest Expenses was $200000.0 in Q3 2025, compared to $100000.0 in Q2 2025 and $400000.0 in Q1 2025.